Get started
Author

Alfonso Cortés

Observed names: A. Cortes, A. Cortés, Alfonso Cortes, Alfonso Cortes Salgado, Alfonso Cortes-Salgado, Alfonso Cortés Salgado, Alfonso Cortés-Salgado
Observed institutions: Universidad Complutense de Madrid, Instituto de Salud Carlos III, Hospital de Sant Pau, Massachusetts General Hospital, Centre for Biomedical Network Research on Rare Diseases, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas
ORCID: 0000-0003-3006-7583
Observed ORCID: 0000-0003-3006-7583
OpenAlex ID: A5064176394
Early hematopoiesis and developing lymphoid organs in the zebrafish
1999 · Catherine E. Willett, Alfonso Cortes, et al. · Developmental Dynamics · 298
PDF
Live imaging of emerging hematopoietic stem cells and early thymus colonization
2007 · Karima Kissa, Emi Murayama, et al. · Blood · 246
The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
2021 · David García-Bernal, Mariano García-Arranz, et al. · Frontiers in Cell and Developmental Biology · 145
PDF
Human Microbiota and Breast Cancer—Is There Any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine
2021 · Diogo Alpuim Costa, José Guilherme Nobre, et al. · Frontiers in Microbiology · 132
PDF
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
2024 · José Manuel Pérez-García, Javier Cortés, et al. · The Lancet · 125
Adoptive T cell therapy for solid tumors: current landscape and future challenges
2024 · Víctor Albarrán, María San Román, et al. · Frontiers in Immunology · 121
PDF
Heartbeat-Driven Pericardiac Fluid Forces Contribute to Epicardium Morphogenesis
2013 · Marina Peralta, Emily Steed, et al. · Current Biology · 93
PDF
Telomerase Is Essential for Zebrafish Heart Regeneration
2015 · Dorota Bednarek, Juan Manuel González-Rosa, et al. · Cell Reports · 85
The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity
2018 · Rifaquat Rahman, Alfonso Cortes, et al. · Journal of Neuro-Oncology · 45
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
2025 · María Gion, Isabel Blancas, et al. · Nature Medicine · 44
PDF
Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent
2024 · Víctor Albarrán, Patricia Guerrero, et al. · Cancer Immunology Immunotherapy · 35
PDF
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
2021 · J.A. Perez-Fidalgo, A. Cortés, et al. · ESMO Open · 31
PDF
Systemic Therapy for HER2-Positive Metastatic Breast Cancer: Moving Into a New Era
2022 · Maria Gion, Dario Trapani, et al. · American Society of Clinical Oncology Educational Book · 30
Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity
2023 · Jesús Chamorro Pérez, Alfonso Cortes Salgado, et al. · Current Oncology Reports · 28
PDF
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments
2022 · Alfonso Cortés, José L. Casado, et al. · European Journal of Cancer · 28
PDF
Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study
2024 · Francesco Schettini, Eva Blondeaux, et al. · Cancer · 23
PDF
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study
2020 · Ignacio Romero, M. Jesús Rubio, et al. · Gynecologic Oncology · 20
T‐dependent areas in the chicken bursa of fabricius: An immunohistological study
1995 · Alfonso Cortés, Jose Fonfría, et al. · The Anatomical Record · 18
Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases
2022 · Silvia González-Martínez, David Pizarro, et al. · Cancers · 13
PDF
3D immunofluorescence analysis of early thymic morphogenesis and medulla development.
2015 · Juan José Muñoz, Teresa Cejalvo, et al. · PubMed · 13
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
2022 · L. de la Cruz-Merino, M. Gion, et al. · BMC Cancer · 11
Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients
2024 · Patricia Guerrero, Víctor Albarrán, et al. · The Oncologist · 10
PDF
Abstract PS16-02: Efficacy and safety of first-line atezolizumab + bevacizumab + paclitaxel in patients with advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
2024 · Maria Gion, Patricia Cortez-Castedo, et al. · Cancer Research · 9
Abstract CT165: A two-stage Simon Design phase II study for NOn-BRCA metastatic BReast cancer (MBC)patients with homologous recombination deficiency treated with OLAparib single agent.(NOBROLA study)
2018 · Elena Aguirre, Kepa Amillano, et al. · Cancer Research · 9
Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors
2024 · Esther Moreno-Moreno, Tamara Caniego-Casas, et al. · The American Journal of Surgical Pathology · 8
Works count: 61
Citation count: 1,659
H-index: 18
I10-index: 22
Year
Topic
Type